The Triple Challenge of Triple Therapy

JACC Cardiovasc Interv. 2016 Aug 22;9(16):1703-5. doi: 10.1016/j.jcin.2016.07.016.

Authors

Jean-Philippe Collet¹, Paul Guedeney², Gilles Montalescot²

Affiliations

¹ ACTION Study Group, Institut de Cardiologie, Pitié-Salpêtrière Hospital (AP-HP), INSERM UMR_S 1166, Université Pierre et Marie Curie (UPMC-Paris 06), Paris, France. Electronic address: jean-philippe.collet@psl.aphp.fr.
² ACTION Study Group, Institut de Cardiologie, Pitié-Salpêtrière Hospital (AP-HP), INSERM UMR_S 1166, Université Pierre et Marie Curie (UPMC-Paris 06), Paris, France.

PMID: 27539690
DOI: 10.1016/j.jcin.2016.07.016

No abstract available

Keywords: atrial fibrillation; oral anticoagulation; perctunaneous coronary intervention; stent.

Publication types

Editorial
Research Support, Non-U.S. Gov't
Comment

MeSH terms

Anticoagulants
Atrial Fibrillation
Drug Therapy, Combination
Platelet Aggregation Inhibitors*
Ticlopidine*

Substances

Anticoagulants
Platelet Aggregation Inhibitors
Ticlopidine